Nutrição e Síndrome do Intestino Irritável – Artigo 16
Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease
Abstract: Intestinal dysbiosis is thought to be an important cause of disease progression and the gastrointestinal symptoms experienced in patients with inflammatory bowel disease (IBD). Inflammation appears to be a major contributor in perpetuating a dysregulated gut microbiota. Although current drug therapies can significantly induce and maintain disease remission, there is no cure for these diseases. Nevertheless, ongoing human studies investigating dietary fibre interventions may potentially prove to ...
Nutrição e Síndrome do Intestino Irritável – Artigo 8
Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases?
Inflammatory bowel disease treatment challenges Inflammatory bowel disease (IBD) is a broad term that describes conditions with chronic,
recurring immune responses and inflammation of the GI tract, which result in severe abdominal cramping and diarrhea. The two
most common forms of IBD are ulcerative colitis (UC), in which inflammation affects the large intestine, and Crohn’s disease (CD),
in which the entire digestive tract is affected. IBD is most common in developed ...
Nutrição e Síndrome do Intestino Irritável – Artigo 20
Why Are Omics Technologies Important to Understanding the Role of Nutrition in Inflammatory Bowel Diseases?
Abstract: For many years, there has been confusion about the role that nutrition plays in inflammatory bowel diseases (IBD). It is apparent that good dietary advice for one individual may prove inappropriate for another. As with many diseases, genome-wide a ssociation studies across large collaborative groups have been important in revealing the role of genetics in IBD, with more than 200 genes associated with susceptibility to the disease. These associations provide clues to ...
Nutrição e Síndrome do Intestino Irritável – Artigo 19
The Specific Carbohydrate Diet for Inflammatory Bowel Disease: A Case Series
THE PATHOGENESIS OF INFLAmmatory bowel disease (IBD) is thought to be multifactorial, involving a genetically susceptible
individual being exposed to a yetto-be identified environmental trigger or set of triggers. There is growing evidence that IBD may be a disease of Westernization associated with diets high in refined sugars; bread and cereals; proteins, especially dairy; and n-6 polyunsaturated fatty acids acquired from highly processed seed oils. However, the evidence is often low quality, confli...
Nutrição e Síndrome do Intestino Irritável – Artigo 18
The Effect of anti-TNFα Induction Therapy on the Nutritional Status and Dietary Intake in Inflammatory Bowel Disease
Background & Aims: Patients suffering from inflammatory bowel disease (IBD) are at a high risk of malnutrition and retain an altered body composition. We hypothesized that anti-tumor necrosis factor (anti-TNF) alpha therapy may improve dietary intake and have a beneficial influence on body composition in these patients.
Nutrição e Síndrome do Intestino Irritável – Artigo 17
Role of Diet in Inflammatory Bowel Disease
The incidence of inflammatory bowel disease (IBD) is steadily in the rise in Western as well as in developing countries paralleling the increase of westernized diets, characterized by high protein and fat as well as excessive sugar intake, with less vegetables and fiber. An interesting hypothesis is that environmental (food-) triggered changes of the intestinal microbiome might cause a proinflammatory state preceding the development of IBD. Indeed, an intact intestinal epithelial barrier assuring a normal bacterial clearance of the intest...
Nutrição e Síndrome do Intestino Irritável – Artigo 15
Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial.
Abstract
Background: Canine inflammatory bowel disease (IBD) is a chronic enteropathy of unknown etiology, although microbiome dysbiosis, genetic susceptibility, and dietary and/or environmental factors are hypothesized to be involved in its pathogenesis. Since some of the current therapies are associated with severe side effects, novel therapeutic modalities are needed. A new oral supplement for long-term management of canine IBD containing chond...
